L. Lavreys

发表

Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men.

J. Baeten, B. Richardson, K. Mandaliya, 2004, The Journal of infectious diseases.

Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

B. Chohan, B. Richardson, S. Hillier, 1999, The Journal of infectious diseases.

Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa

W. Miller, N. Garrett, G. Fegan, 2015, AIDS.

Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels

Dorothy M. Lang, B. Korber, B. Chohan, 2005, Journal of Virology.

Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya.

M. Thompson, K. Mandaliya, J. Bwayo, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study

J. Baeten, K. Mandaliya, J. Ndinya-Achola, 2006, AIDS.

Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS.

M. Opravil, P. Lim, T. van de Casteele, 2013, International journal of STD & AIDS.

A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya

J. Overbaugh, K. Mandaliya, W. Jaoko, 2009, Sexually Transmitted Infections.

A Prospective Study of Risk Factors for Bacterial Vaginosis in HIV-1-Seronegative African Women

J. Baeten, R. McClelland, B. Richardson, 2008, Sexually transmitted diseases.

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

J. Baeten, R. McClelland, K. Holmes, 2008, The Journal of infectious diseases.

Associations Between Intravaginal Practices and Bacterial Vaginosis in Kenyan Female Sex Workers Without Symptoms of Vaginal Infections

K. Holmes, B. Richardson, K. Mandaliya, 2006, Sexually transmitted diseases.

Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study.

J. Baeten, R. McClelland, J. Overbaugh, 2005, The Journal of infectious diseases.

Micronutrient Supplementation Increases Genital Tract Shedding of HIV-1 in Women: Results of a Randomized Trial

J. Baeten, R. McClelland, J. Overbaugh, 2004, Journal of acquired immune deficiency syndromes.

Human herpesvirus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya.

B. Chohan, B. Richardson, L. Corey, 2003, The Journal of infectious diseases.

Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.

B. Chohan, B. Richardson, K. Mandaliya, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya

J. Baeten, B. Chohan, B. Richardson, 2002, AIDS.

Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data.

L. Chen, M. Nelson, L. Lavreys, 2010, The Journal of antimicrobial chemotherapy.

Relationship between markers of HIV-1 disease progression and serum β-carotene concentrations in Kenyan women

K. Mandaliya, L. Lavreys, R. Scott McClelland, 2007, International journal of STD & AIDS.

A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression.

J. Baeten, R. McClelland, J. Overbaugh, 2007, AIDS research and human retroviruses.

Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women

J. Baeten, R. McClelland, P. Drain, 2006, BMC infectious diseases.

Vitamin A deficiency and the acute phase response among HIV-1-infected and -uninfected women in Kenya.

J. Baeten, R. McClelland, J. Overbaugh, 2002 .

HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus.

J. Overbaugh, K. Mandaliya, L. Lavreys, 2002, AIDS research and human retroviruses.

Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial.

J. Baeten, R. McClelland, J. Overbaugh, 2002, The Journal of infectious diseases.

Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya.

M. Thompson, K. Mandaliya, J. Bwayo, 1999, AIDS.

Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response.

J. Baeten, R. McClelland, B. Richardson, 2004, The American journal of clinical nutrition.

Persistent GB Virus C Infection Is Associated with Decreased HIV-1 Disease Progression in the Amsterdam Cohort Study

J. Baeten, B. Richardson, L. Lavreys, 2010 .

Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya.

B. Chohan, K. Mandaliya, M. Thompson, 1999, The Journal of infectious diseases.

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.

T. Harrer, J. van Lunzen, G. Fätkenheuer, 2014, Vaccine.

Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study

J. Baeten, R. McClelland, J. Overbaugh, 2007, BMC infectious diseases.

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis

K. Ruxrungtham, M. Nelson, L. Lavreys, 2009, AIDS.

Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study

J. Baeten, J. Overbaugh, K. Mandaliya, 2004, AIDS.

Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women

J. Baeten, R. McClelland, J. Overbaugh, 2004, AIDS.

Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

J. Baeten, L. Sangaré, K. Mandaliya, 2007, The Journal of infectious diseases.

High levels of cervical HIV-1 RNA during early HIV-1 infection

J. Baeten, R. McClelland, J. Overbaugh, 2006, AIDS.

Pharmacokinetics of Darunavir/Ritonavir and Rifabutin Coadministered in HIV-Negative Healthy Volunteers

T. van de Casteele, L. Lavreys, R. Hoetelmans, 2010, Antimicrobial Agents and Chemotherapy.

Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data

J. Lundgren, V. Calvez, F. Ceccherini‐Silberstein, 2015, HIV medicine.

Pharmacokinetics of darunavir after administration of an oral suspension with low‐dose ritonavir and with or without food

M. Vanstockem, L. Lavreys, T. Kakuda, 2014, Clinical pharmacology in drug development.

HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers

J. Baeten, B. Richardson, K. Mandaliya, 2006, AIDS.

A Prospective Study of Risk Factors for Bacterial Vaginosis in African Women

R. McClelland, B. Richardson, K. Mandaliya, 2008 .

Trends in HIV‐1 Incidence in a Cohort of Prostitutes in Kenya: Implications for HIV‐1 Vaccine Efficacy Trials

J. Baeten, B. Richardson, K. Mandaliya, 2000, Journal of acquired immune deficiency syndromes.

Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.

B. Richardson, K. Mandaliya, J. Ndinya-Achola, 1998, The Journal of infectious diseases.

Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

C. Orrell, L. Lavreys, T. Kakuda, 2015, AIDS research and treatment.

The effect of hormonal contraception on genital tract shedding of HIV-1

R. McClelland, B. Chohan, J. Overbaugh, 2004, AIDS.

Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.

B. Chohan, B. Richardson, L. Corey, 2004, The Journal of infectious diseases.

The influence of hormonal contraceptive use on HIV-1 transmission and disease progression.

J. Baeten, J. Overbaugh, L. Lavreys, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.

J. Baeten, R. McClelland, J. Overbaugh, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.

J. Baeten, R. McClelland, A. Wald, 2004, The Journal of infectious diseases.

Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population

J. Baeten, J. Overbaugh, B. Richardson, 2004, AIDS.

Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women.

J. Baeten, B. Chohan, J. Overbaugh, 2004, The Journal of infectious diseases.

Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression

Barbra A. Richardson, J. Baeten, B. Chohan, 2003, Journal of Virology.

Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.

J. Baeten, B. Chohan, B. Richardson, 2001, American journal of obstetrics and gynecology.

Treatment of cervicitis is associated with decreased cervical shedding of HIV-1

R. McClelland, J. Overbaugh, K. Mandaliya, 2001, AIDS.

Gender differences in HIV-1 diversity at time of infection

J. Overbaugh, K. Mandaliya, L. Lavreys, 2000, Nature Medicine.

CORRELATES FOR HUMAN IMMUNODEFIENCY VIRUS TYPE 1 ACQUISITION AND SUBSEQUENT DISEASE PROGRESSION IN WOMEN

L. Lavreys, 2004 .

Quantification of Genital Human Immunodeficiency Virus Type 1 (HIV-1) DNA in Specimens from Women with Low Plasma HIV-1 RNA Levels Typical of HIV-1 Nontransmitters

J. Baeten, R. McClelland, J. Overbaugh, 2006, Journal of Clinical Microbiology.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.

Diversity in HIV-1 envelope V1-V3 sequences early in infection reflects sequence diversity throughout the HIV-1 genome but does not predict the extent of sequence diversity during chronic infection.

J. Overbaugh, L. Lavreys, M. Sagar, 2006, AIDS research and human retroviruses.

HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.

Bhavna Chohan, J. Baeten, R. McClelland, 2007, The Journal of infectious diseases.

Comparison of Human Immunodeficiency Virus Type 1 Viral Loads in Kenyan Women, Men, and Infants during Primary and Early Infection

Barbra A. Richardson, Ruth Nduati, J. Overbaugh, 2003, Journal of Virology.

Evidence for Frequent Reinfection with Human Immunodeficiency Virus Type 1 of a Different Subtype

Bhavna Chohan, B. Chohan, J. Overbaugh, 2005, Journal of Virology.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Abstracts from the 4th Annual Student Medical Summit

Alisha, D. Ahern, J. Butler, 2021, BMC Proceedings.

Vitamin A Deficiency and the Acute Phase Response Among HIV‐1‐Infected and ‐Uninfected Women in Kenya

J. Baeten, J. Overbaugh, B. Richardson, 2002, Journal of acquired immune deficiency syndromes.

Community and International Nutrition HIV-1 Infection Alters the Retinol-Binding Protein:Transthyretin Ratio Even in the Absence of the Acute Phase Response

J. Baeten, R. McClelland, B. Richardson, 2006 .

Community and International Nutrition HIV-1 Infection Alters the Retinol-Binding Protein : Transthyretin Ratio Even in the Absence of the Acute Phase Response 1

J. Baeten, R. McClelland, B. Richardson, 2006 .

Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion

J. Baeten, R. McClelland, J. Overbaugh, 2019, AIDS.

Oral abstracts of the 10th IAS Conference on HIV Science, 21‐24 July 2019, Mexico City, Mexico

R. J. Cadigan, L. Lavreys, A. Corneli, 2019, Journal of the International AIDS Society.

Evaluation of a Low-Dose Nonoxynol-9 Gel for the Prevention of Sexually Transmitted Diseases: A Randomized Clinical Trial

B. Richardson, K. Mandaliya, E. Ngugi, 2001, Sexually transmitted diseases.

Virological Characterization of Patients Failing Darunavir/Ritonavir or Lopinavir/Ritonavir Treatment in the Artemis Study: 96-Week Analysis

M. de Béthune, T. van de Casteele, L. Lavreys, 2011, Antiviral therapy.

Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women.

J. Baeten, B. Chohan, J. Overbaugh, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Validation of a Modified Commercial Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus Type 1 Immunoglobulin G Antibodies in Saliva

B. Chohan, K. Mandaliya, J. Bwayo, 2001, Clinical Diagnostic Laboratory Immunology.

Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women

J. Baeten, R. McClelland, J. Overbaugh, 2007, AIDS.

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).

H. Schuitemaker, G. Alter, F. Wegmann, 2020, The lancet. HIV.

Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya.

B. Chohan, J. Overbaugh, B. Richardson, 1999, The Journal of infectious diseases.

Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial

H. Crauwels, L. Lavreys, E. Arathoon, 2017, SAGE open medicine.

Impact of an alarm device on medication compliance in women in Mombasa, Kenya

K. Mandaliya, L. Lavreys, J. Kreiss, 2001, International journal of STD & AIDS.

Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96

A. Lazzarin, J. Flamm, T. van de Casteele, 2011, HIV clinical trials.

Effect of Contraceptive Methods on Natural History of HIV: Studies from the Mombasa Cohort

J. Baeten, B. Chohan, J. Overbaugh, 2005, Journal of acquired immune deficiency syndromes.

Secondary transmission of HIV by aware seropositives

L. Lavreys, E. Declercq, D. V. Hove, 1995, The Lancet.

Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity

C. Verhofstede, M. Pau, K. Vercauteren, 2023, Microbiology spectrum.

A Comparison of Genital HIV-1 Shedding and Sexual Risk Behavior Among Kenyan Women Based on Eligibility for Initiation of HAART According to WHO Guidelines

J. Baeten, J. Overbaugh, B. Richardson, 2006, Journal of acquired immune deficiency syndromes.

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees

M. Seaman, R. Coombs, P. D’Souza, 2020, Open forum infectious diseases.

HIV-1 infection alters the retinol-binding protein:transthyretin ratio even in the absence of the acute phase response.

J. Baeten, R. McClelland, B. Richardson, 2006, The Journal of nutrition.

Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults

H. Crauwels, L. Lavreys, E. Arathoon, 2014, Journal of the International AIDS Society.

Evaluation of a low- dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomised clinical trial, Sex Transm Dis 2001

B. Richardson, K. Mandaliya, J. Bwayo, 2001 .

Associations Between Intravaginal Practices and Bacterial Vaginosis in Kenyan Female Sex Workers Without Symptoms of Vaginal Infections

R. McClelland, B. Richardson, K. Mandaliya, 2006, Sexually transmitted diseases.

Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on lipid parameters and anthropometrics in treatment-naïve, HIV-1-infected ARTEMIS patients …

J. Morales-Ramirez, L. Lavreys, E. Baraldi, 2009 .

Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya.

K. Mandaliya, L. Lavreys, J. Kreiss, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.